search
Back to results

dHACM in Lumbar Decompression and Microdiscectomy Surgery

Primary Purpose

Scarring, Spinal Stenosis, Herniated Disc

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Lumbar Decompression Surgery
Microdiscectomy Surgery
Dehydrated Human Amnion/Chorion Membrane (dHACM)
Sponsored by
MiMedx Group, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Scarring

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Are 18 (eighteen) years of age or older at the time of surgery.
  2. Patients with single- or multi-level spinal stenosis undergoing open lumbar laminectomy, or patients with single-level herniated nucleus pulposus undergoing single-level lumbar microdiscectomy
  3. Are willing and able to return for the scheduled follow-up visits, follow post operative instructions and undergo the required radiographic exams for up to 5 time points between 4 weeks and 24 months post-surgery (6 weeks ± 2 weeks, 12 weeks ± 2 weeks, 6 months ±1 month, 1 year±2 months, and 2 years ±2 months post-surgery), including one study MRI-scan at 12 weeks ±2 weeks for the first 20 patients enrolled.
  4. Are willing and able to sign study specific informed consent.

Exclusion Criteria:

  1. Non-English speaking patients
  2. Non-surgical candidate defined as any patient deemed by the surgeon not to be a surgical candidate cannot participate for the following reasons: that patient does not meet indications for lumbar laminectomy or microdiscectomy surgery, patient has a contraindication to surgery such as medical comorbidities, pregnancy, etc.
  3. Allergic to aminoglycoside antibiotics
  4. Is a prisoner
  5. Is involved in worker's compensation or other litigation relative to the spine injury
  6. Has a history of drug or alcohol abuse within the last 12 months
  7. Is currently participating in another drug or device clinical trial
  8. Previous spinal surgery
  9. History of deformity, mechanical instability, or spinal fusion requirement
  10. History of hard- or soft-tissue spinal infection
  11. Has signs or symptoms of any disease, such as autoimmune disease, which could result in allograft failure, or has experienced allograft failure in the past
  12. Patients unable to undergo a MRI

Sites / Locations

  • Hospital for Special Surgery

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

dHACM

Surgery without dHACM

Arm Description

Lumbar Decompression Surgery or Microdiscectomy Surgery with Application of Dehydrated Human Amnion/Chorion Membrane (dHACM)

Control Group - Lumbar Decompression Surgery or Microdiscectomy Surgery without application of dHACM

Outcomes

Primary Outcome Measures

Oswestry Disability Index
Patient Functional Outcomes Questionnaire

Secondary Outcome Measures

Re-operation (Number of patients having re-operation during study)
Number of patients having re-operation during study
Scar formation in revision cases
Dissection of scar formation required at re-operation
Quality of Life (VAS Pain)
VAS Pain
Quality of Life (SF-36)
SF-36
Quality of Life
HSS Lumbar Expectations Survey

Full Information

First Posted
November 18, 2014
Last Updated
August 22, 2018
Sponsor
MiMedx Group, Inc.
Collaborators
Hospital for Special Surgery, New York
search

1. Study Identification

Unique Protocol Identification Number
NCT02300909
Brief Title
dHACM in Lumbar Decompression and Microdiscectomy Surgery
Official Title
A Randomized, Single Blind, Controlled Trial of Clinical Outcomes of Dehydrated Human Amnion/Chorion Membrane (dHACM) in Lumbar Decompression and Microdiscectomy Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
November 2014 (undefined)
Primary Completion Date
June 2018 (Actual)
Study Completion Date
June 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
MiMedx Group, Inc.
Collaborators
Hospital for Special Surgery, New York

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Prospective evaluation of the safety and efficacy of dHACM on clinical outcomes in lumbar laminectomy and microdiscectomy patients as assessed by Oswestry Disability Index.
Detailed Description
The objective of this prospective study is to evaluate the safety and efficacy of dHACM on clinical outcomes in lumbar laminectomy and microdiscectomy patients randomized to one of two groups: 1) without dHACM (control) or 2) dHACM.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Scarring, Spinal Stenosis, Herniated Disc

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
143 (Actual)

8. Arms, Groups, and Interventions

Arm Title
dHACM
Arm Type
Experimental
Arm Description
Lumbar Decompression Surgery or Microdiscectomy Surgery with Application of Dehydrated Human Amnion/Chorion Membrane (dHACM)
Arm Title
Surgery without dHACM
Arm Type
Other
Arm Description
Control Group - Lumbar Decompression Surgery or Microdiscectomy Surgery without application of dHACM
Intervention Type
Procedure
Intervention Name(s)
Lumbar Decompression Surgery
Intervention Description
Lumbar Decompression Surgery
Intervention Type
Procedure
Intervention Name(s)
Microdiscectomy Surgery
Intervention Description
Microdiscectomy Surgery
Intervention Type
Other
Intervention Name(s)
Dehydrated Human Amnion/Chorion Membrane (dHACM)
Intervention Description
Application of Dehydrated Human Amnion/Chorion Membrane (dHACM)
Primary Outcome Measure Information:
Title
Oswestry Disability Index
Description
Patient Functional Outcomes Questionnaire
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Re-operation (Number of patients having re-operation during study)
Description
Number of patients having re-operation during study
Time Frame
2 years
Title
Scar formation in revision cases
Description
Dissection of scar formation required at re-operation
Time Frame
2 years
Title
Quality of Life (VAS Pain)
Description
VAS Pain
Time Frame
2 years
Title
Quality of Life (SF-36)
Description
SF-36
Time Frame
2 years
Title
Quality of Life
Description
HSS Lumbar Expectations Survey
Time Frame
2 years
Other Pre-specified Outcome Measures:
Title
MRI findings in first 20 patients
Time Frame
3 months post-op

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Are 18 (eighteen) years of age or older at the time of surgery. Patients with single- or multi-level spinal stenosis undergoing open lumbar laminectomy, or patients with single-level herniated nucleus pulposus undergoing single-level lumbar microdiscectomy Are willing and able to return for the scheduled follow-up visits, follow post operative instructions and undergo the required radiographic exams for up to 5 time points between 4 weeks and 24 months post-surgery (6 weeks ± 2 weeks, 12 weeks ± 2 weeks, 6 months ±1 month, 1 year±2 months, and 2 years ±2 months post-surgery), including one study MRI-scan at 12 weeks ±2 weeks for the first 20 patients enrolled. Are willing and able to sign study specific informed consent. Exclusion Criteria: Non-English speaking patients Non-surgical candidate defined as any patient deemed by the surgeon not to be a surgical candidate cannot participate for the following reasons: that patient does not meet indications for lumbar laminectomy or microdiscectomy surgery, patient has a contraindication to surgery such as medical comorbidities, pregnancy, etc. Allergic to aminoglycoside antibiotics Is a prisoner Is involved in worker's compensation or other litigation relative to the spine injury Has a history of drug or alcohol abuse within the last 12 months Is currently participating in another drug or device clinical trial Previous spinal surgery History of deformity, mechanical instability, or spinal fusion requirement History of hard- or soft-tissue spinal infection Has signs or symptoms of any disease, such as autoimmune disease, which could result in allograft failure, or has experienced allograft failure in the past Patients unable to undergo a MRI
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alexander Hughes, MD
Organizational Affiliation
Hospital for Special Surgery, New York
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital for Special Surgery
City
New York
State/Province
New York
ZIP/Postal Code
10021
Country
United States

12. IPD Sharing Statement

Learn more about this trial

dHACM in Lumbar Decompression and Microdiscectomy Surgery

We'll reach out to this number within 24 hrs